Wei‐Ting Hwang

26.6k total citations · 6 hit papers
271 papers, 14.1k citations indexed

About

Wei‐Ting Hwang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Wei‐Ting Hwang has authored 271 papers receiving a total of 14.1k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Oncology, 49 papers in Pulmonary and Respiratory Medicine and 44 papers in Cancer Research. Recurrent topics in Wei‐Ting Hwang's work include CAR-T cell therapy research (38 papers), Breast Cancer Treatment Studies (31 papers) and Bladder and Urothelial Cancer Treatments (22 papers). Wei‐Ting Hwang is often cited by papers focused on CAR-T cell therapy research (38 papers), Breast Cancer Treatment Studies (31 papers) and Bladder and Urothelial Cancer Treatments (22 papers). Wei‐Ting Hwang collaborates with scholars based in United States, Egypt and Netherlands. Wei‐Ting Hwang's co-authors include Ann E. Rogers, Linda D. Scott, Lawrence J. Solin, Carl H. June, Eleanor Harris, Bruce L. Levine, David F. Dinges, Anne E. Kazak, Linda H. Aiken and Curtiland Deville and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Wei‐Ting Hwang

261 papers receiving 13.6k citations

Hit Papers

Chimeric antigen receptor T cells persist a... 2004 2026 2011 2018 2015 2014 2004 2012 2011 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
    2015 1.3k citations Wei‐Ting Hwang, Noelle V. Frey et al. profile →
  2. Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
    2014 973 citations Ian Frank, Wei‐Ting Hwang et al. profile →
  3. The Working Hours Of Hospital Staff Nurses And Patient Safety
    2004 720 citations Wei‐Ting Hwang et al. profile →
  4. Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells
    2012 502 citations Wei‐Ting Hwang et al. profile →
  5. Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
    2011 491 citations Wei‐Ting Hwang et al. profile →
  6. Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma
    2015 434 citations Wei‐Ting Hwang, Edward A. Stadtmauer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei‐Ting Hwang United States 55 5.5k 2.8k 1.9k 1.7k 1.6k 271 14.1k
Anthony J. Swerdlow United Kingdom 73 5.6k 1.0× 3.0k 1.1× 1.3k 0.7× 847 0.5× 2.9k 1.9× 283 16.9k
Adèle C. Green Australia 80 9.9k 1.8× 3.6k 1.3× 1.2k 0.6× 1.4k 0.8× 1.8k 1.2× 516 23.9k
Geertruida H. de Bock Netherlands 65 5.9k 1.1× 2.2k 0.8× 3.0k 1.6× 1.2k 0.7× 1.9k 1.2× 650 18.7k
Li Liu China 61 4.2k 0.8× 6.0k 2.1× 3.4k 1.8× 2.0k 1.1× 715 0.5× 663 18.1k
Robert N. Anderson United States 55 7.1k 1.3× 2.8k 1.0× 2.0k 1.1× 609 0.3× 790 0.5× 118 19.5k
Elisabete Weiderpass Sweden 75 8.0k 1.5× 3.5k 1.2× 2.4k 1.3× 820 0.5× 2.3k 1.5× 508 26.8k
Peter J. Selby United Kingdom 73 8.2k 1.5× 7.1k 2.5× 2.0k 1.1× 2.4k 1.4× 2.6k 1.6× 339 19.8k
Hang Lee United States 82 4.2k 0.8× 4.7k 1.6× 731 0.4× 964 0.6× 2.3k 1.5× 440 26.2k
Liam Murray United Kingdom 61 3.0k 0.5× 2.8k 1.0× 1.5k 0.8× 1.3k 0.7× 770 0.5× 282 16.5k
Betsy Kohler United States 30 6.2k 1.1× 2.6k 0.9× 2.0k 1.1× 483 0.3× 670 0.4× 61 13.9k

Countries citing papers authored by Wei‐Ting Hwang

Since Specialization
Citations

This map shows the geographic impact of Wei‐Ting Hwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Ting Hwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Ting Hwang more than expected).

Fields of papers citing papers by Wei‐Ting Hwang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Ting Hwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Ting Hwang. The network helps show where Wei‐Ting Hwang may publish in the future.

Co-authorship network of co-authors of Wei‐Ting Hwang

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Ting Hwang. A scholar is included among the top collaborators of Wei‐Ting Hwang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Ting Hwang. Wei‐Ting Hwang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riedell, Peter A., Loretta J. Nastoupil, Alejandro Luna, et al.. (2024). Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysis. Blood Advances. 9(5). 1232–1241. 6 indexed citations
2.
3.
Marmarelis, Melina E., Caroline E. McCoach, Geoffrey Liu, et al.. (2023). Characteristics of long-term survivors with EGFR mutant (EGFRm) metastatic non-small cell lung cancer (mNSCLC).. Journal of Clinical Oncology. 41(16_suppl). 9116–9116.
4.
Wethington, Stephanie L., Payal D. Shah, Lainie P. Martin, et al.. (2023). C ombination A TR (ceralasertib) and P A R P (olaparib) I nhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer. Clinical Cancer Research. 29(15). 2800–2807. 40 indexed citations
5.
Sun, Lova, Joshua E. Reuss, Geoffrey Liu, et al.. (2023). P2.31-05 Determining Lines of Therapy in Patients with Metastatic Non-Small Cell Lung Cancer Using Real-World Data. Journal of Thoracic Oncology. 18(11). S408–S409.
6.
Li, Yimei, Wei‐Ting Hwang, Shannon L. Maude, et al.. (2022). Statistical Considerations for Analyses of Time-To-Event Endpoints in Oncology Clinical Trials: Illustrations with CAR-T Immunotherapy Studies. Clinical Cancer Research. 28(18). 3940–3949. 8 indexed citations
7.
Matthews, Andrew, Alexander E. Perl, Selina M. Luger, et al.. (2022). Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia. Blood Advances. 6(13). 3997–4005. 53 indexed citations
8.
Hwang, Wei‐Ting, et al.. (2022). Modeling post-holiday surge in COVID-19 cases in Pennsylvania counties. PLoS ONE. 17(12). e0279371–e0279371. 2 indexed citations
9.
Chapin, William J., Wei‐Ting Hwang, Thomas B. Karasic, Anne Marie McCarthy, & David E. Kaplan. (2022). Comparison of nivolumab and sorafenib for first systemic therapy in patients with hepatocellular carcinoma and Child‐Pugh B cirrhosis. Cancer Medicine. 12(1). 189–199. 15 indexed citations
10.
Bircsak, Kristin M., et al.. (2020). The aryl hydrocarbon receptor mediates sex ratio distortion in the embryos sired by TCDD-exposed male mice. Reproductive Toxicology. 94. 75–83. 8 indexed citations
11.
Vann, David R., et al.. (2020). A mineralogical and chemical investigation of road dust in Philadelphia, PA, USA. Environmental Science and Pollution Research. 27(13). 14883–14902. 27 indexed citations
12.
Sun, Lova, Christiana Davis, Wei‐Ting Hwang, et al.. (2020). Outcomes in Patients With Non–small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based Therapy. Clinical Lung Cancer. 22(1). 58–66.e3. 30 indexed citations
13.
DiLorenzo, Michael P., Wei‐Ting Hwang, Elizabeth Goldmuntz, Bonnie Ky, & Laura Mercer‐Rosa. (2018). Diastolic dysfunction in tetralogy of Fallot: Comparison of echocardiography with catheterization. Echocardiography. 35(10). 1641–1648. 22 indexed citations
14.
Chawla, Sanjeev, Laurie A. Loevner, Sungheon Kim, et al.. (2017). Dynamic Contrast-Enhanced MRI–Derived Intracellular Water Lifetime (τi): A Prognostic Marker for Patients with Head and Neck Squamous Cell Carcinomas. American Journal of Neuroradiology. 39(1). 138–144. 22 indexed citations
15.
Zhong, Qian, Hongling Peng, Xia Zhao, Lin Zhang, & Wei‐Ting Hwang. (2014). Effects of BRCA1 - and BRCA2 -Related Mutations on Ovarian and Breast Cancer Survival: A Meta-analysis. Clinical Cancer Research. 21(1). 211–220. 140 indexed citations
16.
Jang, Joanne, Wei‐Ting Hwang, Thomas J. Guzzo, et al.. (2012). Upfront Androgen Deprivation Therapy With Salvage Radiation May Improve Biochemical Outcomes in Prostate Cancer Patients With Post-Prostatectomy Rising PSA. International Journal of Radiation Oncology*Biology*Physics. 83(5). 1493–1499. 13 indexed citations
17.
Correa, Candace R., Harold Litt, Wei‐Ting Hwang, et al.. (2007). Coronary Artery Findings After Left-Sided Compared With Right-Sided Radiation Treatment for Early-Stage Breast Cancer. Journal of Clinical Oncology. 25(21). 3031–3037. 303 indexed citations
18.
Harris, Eleanor, Wei‐Ting Hwang, Keith A. Cengel, et al.. (2006). The Impact of HER-2 Status on Local Recurrence in Women with Stage I?II Breast Cancer Treated with Breast-Conserving Therapy. The Breast Journal. 12(5). 431–436. 15 indexed citations
19.
Bisson, Gregory P., Brian L. Strom, Robert Gross, et al.. (2005). Effect of GB virus C viremia on HIV acquisition and HIV set-point. AIDS. 19(16). 1910–1912. 10 indexed citations
20.
Kazak, Anne E., Steven Simms, Melissa A. Alderfer, et al.. (2005). Feasibility and Preliminary Outcomes from a Pilot Study of a Brief Psychological Intervention for Families of Children Newly Diagnosed with Cancer. Journal of Pediatric Psychology. 30(8). 644–655. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anthony J. Swerdlow Breakdown of academic impact, for papers by Adèle C. Green Breakdown of academic impact, for papers by Geertruida H. de Bock Breakdown of academic impact, for papers by Li Liu Breakdown of academic impact, for papers by Robert N. Anderson Breakdown of academic impact, for papers by Elisabete Weiderpass Breakdown of academic impact, for papers by Peter J. Selby Breakdown of academic impact, for papers by Hang Lee Breakdown of academic impact, for papers by Liam Murray Breakdown of academic impact, for papers by Betsy Kohler
Rankless by CCL
2026